Exploring the association between de novo mutations and non-syndromic cleft lip with or without palate based on whole exome sequencing of case-parent trios

  • Xi CHEN ,
  • Si-yue WANG ,
  • En-ci XUE ,
  • Xue-heng WANG ,
  • He-xiang PENG ,
  • Meng FAN ,
  • Meng-ying WANG ,
  • Yi-qun WU ,
  • Xue-ying QIN ,
  • Jing LI ,
  • Tao WU ,
  • Hong-ping ZHU ,
  • Jing LI ,
  • Zhi-bo ZHOU ,
  • Da-fang CHEN ,
  • Yong-hua HU
Expand
  • 1. Department of Epidemiology and Biostatistics, Peking University School of Public Health, Beijing 100191, China
    2. Department of Oral and Maxillofacial Surgery, Peking University School and Hospital of Stomatology & National Center of Stomatology & National Clinical Research Center for Oral Diseases & National Engineering Research Center of Oral Biomaterials and Digital Medical Devices & Beijing Key Laboratory of Digital Stomatology & NHC Research Center of Engineering and Technology for Computerized Dentistry & NMPA Key Laboratory for Dental Materials, Beijing 100081, China
    3. Department of Pediatric Dentistry, Peking University School and Hospital of Stomatology & National Center of Stomatology & National Clinical Research Center for Oral Diseases & National Engineering Research Center of Oral Biomaterials and Digital Medical Devices & Beijing Key Laboratory of Digital Stomatology & NHC Research Center of Engineering and Technology for Computerized Dentistry & NMPA Key Laboratory for Dental Materials, Beijing 100081, China

Received date: 2022-02-24

  Online published: 2022-06-14

Supported by

the National Natural Science Foundation of China(81573225);the National Natural Science Foundation of China(81102178);the Natural Science Foundation of Beijing(7172115)

Abstract

Objective: To explore the association between de novo mutations (DNM) and non-syndromic cleft lip with or without palate (NSCL/P) using case-parent trio design. Methods: Whole-exome sequencing was conducted for twenty-two NSCL/P trios and Genome Analysis ToolKit (GATK) was used to identify DNM by comparing the alleles of the cases and their parents. Information of predictable functions was annotated to the locus with SnpEff. Enrichment analysis for DNM was conducted to test the difference between the actual number and the expected number of DNM, and to explore whether there were genes with more DNM than expected. NSCL/P-related genes indicated by previous studies with solid evidence were selected by literature reviewing. Protein-protein interactions analysis was conducted among the genes with protein-altering DNM and NSCL/P-related genes. R package "denovolyzeR" was used for the enrichment analysis (Bonferroni correction: P=0.05/n, n is the number of genes in the whole genome range). Protein-protein interactions among genes with DNM and genes with solid evidence on the risk factors of NSCL/P were predicted depending on the information provided by STRING database. Results: A total of 339 908 SNPs were qualified for the subsequent analysis after quality control. The number of high confident DNM identified by GATK was 345. Among those DNM, forty-four DNM were missense mutations, one DNM was nonsense mutation, two DNM were splicing site mutations, twenty DNM were synonymous mutations and others were located in intron or intergenic regions. The results of enrichment analysis showed that the number of protein-altering DNM on the exome regions was larger than expected (P < 0.05), and five genes (KRTCAP2, HMCN2, ANKRD36C, ADGRL2 and DIPK2A) had more DNM than expected (P < 0.05/(2×19 618)). Protein-protein interaction analysis was conducted among forty-six genes with protein-altering DNM and thirteen genes associated with NSCL/P selected by literature reviewing. Six pairs of interactions occurred between the genes with DNM and known NSCL/P-related genes. The score measuring the confidence level of the predicted interaction between RGPD4 and SUMO1 was 0.868, which was higher than the scores for other pairs of genes. Conclusion: Our study provided novel insights into the development of NSCL/P and demonstrated that functional analyses of genes carrying DNM were warranted to understand the genetic architecture of complex diseases.

Cite this article

Xi CHEN , Si-yue WANG , En-ci XUE , Xue-heng WANG , He-xiang PENG , Meng FAN , Meng-ying WANG , Yi-qun WU , Xue-ying QIN , Jing LI , Tao WU , Hong-ping ZHU , Jing LI , Zhi-bo ZHOU , Da-fang CHEN , Yong-hua HU . Exploring the association between de novo mutations and non-syndromic cleft lip with or without palate based on whole exome sequencing of case-parent trios[J]. Journal of Peking University(Health Sciences), 2022 , 54(3) : 387 -393 . DOI: 10.19723/j.issn.1671-167X.2022.03.001

References

1 Worley ML , Patel KG , Kilpatrick LA . Cleft lip and palate[J]. Clin Perinatol, 2018, 45 (4): 661- 678.
2 Beaty TH , Murray JC , Marazita ML , et al. A genome-wide association study of cleft lip with and without cleft palate identifies risk variants near MAFB and ABCA4[J]. Nat Genet, 2010, 42 (6): 525- 529.
3 Nasreddine G, El Hajj J, Ghassibe-Sabbagh M. Orofacial clefts embryology, classification, epidemiology, and genetics[J/OL]. Mutat Res Rev Mutat Res, 2021, 787: 108373(2021-02-28)[2022-02-01]. https://pubmed.ncbi.nlm.nih.gov/34083042/.
4 van Rooij IA , Ludwig KU , Welzenbach J , et al. Non-syndromic cleft lip with or without cleft palate: Genome-wide association study in Europeans identifies a suggestive risk locus at 16p12.1 and supports as a clefting susceptibility gene[J]. Genes (Basel), 2019, 10 (12): 1023.
5 Bishop MR , Diaz Perez KK , Sun M , et al. Genome-wide enrichment of de novo coding mutations in orofacial cleft trios[J]. Am J Hum Genet, 2020, 107 (1): 124- 136.
6 Jin ZB , Li Z , Liu Z , et al. Identification of de novo germline mutations and causal genes for sporadic diseases using trio-based whole-exome/genome sequencing[J]. Biol Rev Camb Philos Soc, 2018, 93 (2): 1014- 1031.
7 Conrad DF , Keebler JE , DePristo MA , et al. Variation in genome-wide mutation rates within and between human families[J]. Nat Genet, 2011, 43 (7): 712- 714.
8 Veltman JA , Brunner HG . De novo mutations in human genetic disease[J]. Nat Rev Genet, 2012, 13 (8): 565- 575.
9 Coe BP , Stessman HAF , Sulovari A , et al. Neurodevelopmental disease genes implicated by de novo mutation and copy number variation morbidity[J]. Nat Genet, 2019, 51 (1): 106- 116.
10 Mitra I , Huang B , Mousavi N , et al. Patterns of de novo tandem repeat mutations and their role in autism[J]. Nature, 2021, 589 (7841): 246- 250.
11 Jin SC , Homsy J , Zaidi S , et al. Contribution of rare inherited and de novo variants in 2 871 congenital heart disease probands[J]. Nat Genet, 2017, 49 (11): 1593- 1601.
12 Watkins WS , Hernandez EJ , Wesolowski S , et al. De novo and recessive forms of congenital heart disease have distinct genetic and phenotypic landscapes[J]. Nat Commun, 2019, 10 (1): 4722.
13 Ware JS, Samocha KE, Homsy J, et al. Interpreting de novo variation in human disease using denovolyzeR[J/OL]. Curr Protoc Hum Genet, 2015, 87: 7.25.1 -7.25.15(2015-08-06)[2022-02-01]. https://pubmed.ncbi.nlm.nih.gov/26439716/.
14 Szklarczyk D , Gable AL , Nastou KC , et al. The STRING database in 2021:Customizable protein-protein networks, and functional characterization of user-uploaded gene/measurement sets[J]. Nucleic Acids Res, 2021, 49 (D1): D605- D612.
15 Saleem K , Zaib T , Sun W , et al. Assessment of candidate genes and genetic heterogeneity in human non syndromic orofacial clefts specifically non syndromic cleft lip with or without palate[J]. Heliyon, 2019, 5 (12): e03019.
16 Vezain M , Lecuyer M , Rubio M , et al. A de novo variant in ADGRL2 suggests a novel mechanism underlying the previously undescribed association of extreme microcephaly with severely reduced sulcation and rhombencephalosynapsis[J]. Acta Neuropathol Commun, 2018, 6 (1): 109.
17 Shao R , Liu J , Yan G , et al. Cdh1 regulates craniofacial development via APC-dependent ubiquitination and activation of Goosecoid[J]. Cell Res, 2016, 26 (6): 699- 712.
18 Hamann J , Aust G , Ara? D , et al. International union of basic and clinical pharmacology. XCIV. Adhesion G protein-coupled receptors[J]. Pharmacol Rev, 2015, 67 (2): 338- 367.
19 Sevastre AS , Buzatu IM , Baloi C , et al. ELTD1:An emerging silent actor in cancer drama play[J]. Int J Mol Sci, 2021, 22 (10): 5151.
20 Lek M , Karczewski KJ , Minikel EV , et al. Analysis of protein-coding genetic variation in 60, 706 humans[J]. Nature, 2016, 536 (7616): 285- 291.
21 Huang N , Lee I , Marcotte EM , et al. Characterising and predicting haploinsufficiency in the human genome[J]. PLoS Genet, 2010, 6 (10): e1001154.
22 Hiramatsu H , Tadokoro S , Nakanishi M , et al. Latrotoxin-induced exocytosis in mast cells transfected with latrophilin[J]. Toxicon, 2010, 56 (8): 1372- 1380.
23 Zepeda-Mendoza CJ , Bardon A , Kammin T , et al. Phenotypic interpretation of complex chromosomal rearrangements informed by nucleotide-level resolution and structural organization of chromatin[J]. Eur J Hum Genet, 2018, 26 (3): 374- 381.
24 Passi GR , Bhatnagar S . Rhombencephalosynapsis[J]. Pediatr Neurol, 2015, 52 (6): 651- 652.
25 Birnbaum S , Ludwig KU , Reutter H , et al. Key susceptibility locus for nonsyndromic cleft lip with or without cleft palate on chromosome 8q24[J]. Nat Genet, 2009, 41 (4): 473- 477.
26 Mangold E , Ludwig KU , Birnbaum S , et al. Genome-wide association study identifies two susceptibility loci for nonsyndromic cleft lip with or without cleft palate[J]. Nat Genet, 2010, 42 (1): 24- 26.
27 Beaty TH , Taub MA , Scott AF , et al. Confirming genes influencing risk to cleft lip with/without cleft palate in a case-parent trio study[J]. Hum Genet, 2013, 132 (7): 771- 781.
28 Parry DA , Logan CV , Stegmann AP , et al. SAMS, a syndrome of short stature, auditory-canal atresia, mandibular hypoplasia, and skeletal abnormalities is a unique neurocristopathy caused by mutations in Goosecoid[J]. Am J Hum Genet, 2013, 93 (6): 1135- 1142.
29 Ulmer B , Tingler M , Kurz S , et al. A novel role of the organizer gene Goosecoid as an inhibitor of Wnt/PCP-mediated convergent extension in Xenopus and mouse[J]. Sci Rep, 2017, 7, 43010.
30 Yu Y , Zuo X , He M , et al. Genome-wide analyses of non-syndromic cleft lip with palate identify 14 novel loci and genetic heterogeneity[J]. Nat Commun, 2017, 8, 14364.
31 Kalisz M , Winzi M , Bisgaard HC , et al. EVEN-SKIPPED HOMEOBOX 1 controls human ES cell differentiation by directly repressing GOOSECOID expression[J]. Dev Biol, 2012, 362 (1): 94- 103.
32 Rivera-Pérez JA , Mallo M , Gendron-Maguire M , et al. Goosecoid is not an essential component of the mouse gastrula organizer but is required for craniofacial and rib development[J]. Development, 1995, 121 (9): 3005- 3012.
33 Yamada G , Mansouri A , Torres M , et al. Targeted mutation of the murine goosecoid gene results in craniofacial defects and neonatal death[J]. Development, 1995, 121 (9): 2917- 2922.
34 Feitosa NM , Zhang J , Carney TJ , et al. Hemicentin 2 and fibulin 1 are required for epidermal-dermal junction formation and fin mesenchymal cell migration during zebrafish development[J]. Dev Biol, 2012, 369 (2): 235- 248.
Outlines

/